Neurological disorders Archives

pharnext marie tooth disease IPO pharnext

News and Trends 14 Jul 2016

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

Pharnext has successfully completed its IPO on the Euronext Paris exchange, allowing it to move forward with Phase II and III trials for Neurological diseases that include Alzheimer's. Based in…

July 14, 2016 - 2 minutesmins - By Dani Bancroft

multiple sclerosis zinbryta daclizumab biogen abbvie

News and Trends 6 Jul 2016

Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%

Biogen and AbbVie have been granted EU marketing authorization for Zinbryta (daclizumab), to treat adult patients with relapsing forms of multiple sclerosis. Relapse frequency per year was shown to be reduced by…

July 6, 2016 - 3 minutesmins - By Dani Bancroft

affiris peptide vaccine affitope cholesterol

News and Trends 29 Jun 2016

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

AFFiRiS has received €10M from previous investors and one additional backer, adding up to €130M in total funding (half from grants and licensing incomes). This money fuels a pipeline in cardiometabolic…

June 29, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 Jun 2016

Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial

Axon Neuroscience is starting a Phase II trial with its immunotherapy for Alzheimer's disease, which redirects the immune system against defective Tau proteins, thought to be the main cause of…

June 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

kings college depression biomarker diagnostic

News and Trends 14 Jun 2016

New Biomarkers could make Personalized Medicine for Depression

Researchers from King’s College London have succeeded in developing a blood test that can help choose the best treatment for depression patients - a big improvement over the current trial-and-error approach.…

June 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

huntingtons rochester copenhagen glia transplant

News and Trends 9 Jun 2016

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington's disease in mice with a transplant of healthy human brain cells. This provides a new route to…

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients - a rare neurological disorder. Based near Milan (Italy), Newron is…

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

interview biotrinity labiotech dementia fund

News and Trends 28 Apr 2016

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

I had the chance to talk with Tetsuyuki Maruyama, the CSO of the relatively new Dementia Discovery Fund - our final interview for #BioTrinity2016 in London. The high risk nature…

April 28, 2016 - 1 minutemin - By Philip Hemme

pharnext pleodrug charcot marie tooth cmt1a

News and Trends 27 Apr 2016

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

Pharnext is opening their first US study sites for a phase III trial in a rare neuropathy - a milestone in the development of Pharnext's leading candidate. Based in Paris…

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College…

April 23, 2016 - 4 minutesmins - By Dani Bancroft

cannabis cannabidiol gw pharmaceuticals tuberous sclerosis complex epilepsy biotech fda orphan drug trials

News and Trends 22 Apr 2016

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic form of epilepsy. GW Pharmaceuticals has been granted Orphan Drug…

April 22, 2016 - 2 minutesmins - By Dani Bancroft

Gensight gene therapy biotech bernard gilly labiotech

News and Trends 18 Apr 2016

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO of the Paris biotech GenSight. I wanted to learn more…

April 18, 2016 - 6 minutesmins - By Philip Hemme

geneuro euronext multiple sclerosis biotech

News and Trends 16 Apr 2016

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase IIb trial. Now, as of yesterday they are listed on…

April 16, 2016 - 2 minutesmins - By Dani Bancroft

world parkinson parkinsons disease awareness day CNS biotech neurological neurodegenerative

News and Trends 11 Apr 2016

It’s World Parkinson’s Disease Day! #EndParkinsons

Today (April 11th) is the birthday of the memorable Dr James Parkinson, who discovered this major neurodegenerative disease. So what is Parkinson's Disease, and who is researching it? First described…

April 11, 2016 - 4 minutesmins - By Dani Bancroft

medday multiple sclerosis neurodegenerative disease md1003

News and Trends 11 Apr 2016

French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

MedDay (France) has raised €34M that should help pay a US phase III for its leading candidate for Multiple Sclerosis - as well as its commercial launch in Europe. Based in Paris,…

April 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

heptares allergan neurological alzheimer gpcr

News and Trends 7 Apr 2016

Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech

Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer's, to Allergan for up to €3Bn. A good way for Allergan to 'get over' yesterday's failed…

April 7, 2016 - 3 minutesmins - By Denise Neves Gameiro

probiodrug alzheimers mark booth cbo e1458823157506

News and Trends 24 Mar 2016

Leading German Biotech recruits New talent for Fight against Alzheimer’s

Probiodrug (Germany) has hired Mark Booth as Chief Business Officer to propel this Pharma's global strategy. Among other important roles, Booth was president of Takeda North America. Probiodrug is a…

March 24, 2016 - 2 minutesmins - By Denise Neves Gameiro

migraine biotech cgrps heptares review neurology

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide population. So where are we on fighting a viable therapy…

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

autism spectrum disorder seaside therapeutics asd fragile x biotech

News and Trends 3 Mar 2016

Reviewing Autism: Can Biotech open up New Horizons?

While Autism Spectrum Disorders (ASD) affect approximately one in 68 children, this hasn't provoked much enthusiasm among pharmaceutical companies to develop drugs. However, recent advances in basic research Autism and novel…

March 3, 2016 - 6 minutesmins - By Ekaterina Perets

News and Trends 11 Feb 2016

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Back in 2011, France's biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more than $20 billion, thus becoming the latest global drug giant to acquire a big biotech…

February 11, 2016 - 3 minutesmins - By Dani Bancroft

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering